CoChat

Telmisartan Enhances Cholesterol Efflux from THP-1 Macrophages by Activating PPARγ

Open access
Nakaya, Kazuhiro, Ayaori, Makoto, Hisada, Tetsuya, Sawada, Shojiro, Tanaka, Nobukiyo, Iwamoto, Noriyuki, Ogura, Masatsune, Yakushiji, Emi, Kusuhara, Masatoshi, Nakamura, Haruo, Ohsuzu, Fumitaka · 2007 · Journal of Atherosclerosis and Thrombosis
Cited by 61

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

AIM: The ATP binding cassette transporters A1 and G1 (ABCA1/G1) and scavenger receptor class B type I (SR-BI) are key molecules in cholesterol efflux and atherogenesis. These genes are regulated by peroxisome proliferator-activated receptor gamma (PPARgamma) and liver X receptor (LXR). Telmisartan is an angiotensin type 1 receptor blocker which has been reported to act as a ligand for PPARgamma. We investigated whether PPARgamma-activating ARBs affect the expression of these genes and cholesterol efflux from macrophages. METHODS AND RESULTS: Telmisartan increased ABCA1, ABCG1 and SR-BI mRNA levels in THP-1 macrophages in a dose- and time-dependent fashion. It also increased their protein levels and enhanced apoA-I- and HDL-mediated cholesterol efflux from macrophages. The knockdown of PPARgamma by siRNA abolished the telmisartan-induced expression of these genes. The knockdown of LXRalpha resulted in the complete and partial abolishment of telmisartan-induced ABCA1 and ABCG1 expression, respectively. We also demonstrated that telmisartan-induced SR-BI expression was dependent on the PPARgamma pathway but not on the LXRalpha pathway. A luciferase assay using an ABCA1 promoter construct showed that telmisartan activated ABCA1 transcription, which was abolished if the LXR binding element was mutated, indicating that increased ABCA1 transcription by telmisartan is LXR-dependent. CONCLUSION: Our results showed that telmisartan enhanced both apoA-I- and HDL-mediated cholesterol efflux from macrophages by increasing ABCA1, ABCG1 and SR-BI expression via PPARgamma-dependent and LXR-dependent/independent pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5551/jat.14.133

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 61

Metadata

Authors
Nakaya, K., Ayaori, M., Hisada, T., Sawada, S., Tanaka, N., Iwamoto, N., Ogura, M., Yakushiji, E., Kusuhara, M., Nakamura, H., & Ohsuzu, F.
Venue
Journal of Atherosclerosis and Thrombosis
Published
2007
Volume
14
Issue
3
Pages
133-141
ISSN
  • 1340-3478 (ISSN-L)
  • 1880-3873
OpenAlex
W2045006841
Cited by
61
References
5
FWCI
6.73
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Telmisartan Enhances Cholesterol Efflux from THP-1 Macrophages by Activating PPARγ. https://app.cochat.ai/papers/10.5551/jat.14.133
The paper
Nakaya, K., Ayaori, M., Hisada, T., Sawada, S., Tanaka, N., Iwamoto, N., Ogura, M., Yakushiji, E., Kusuhara, M., Nakamura, H., & Ohsuzu, F. (2007). Telmisartan Enhances Cholesterol Efflux from THP-1 Macrophages by Activating PPARγ. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.14.133

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.